Industry1h ago
Isomorphic Labs Raises $2.1 Billion For Drug Discovery
A $2.1 billion funding round fuels Isomorphic Labs as it scales its Drug Design Engine. The Google DeepMind spinoff partnered with Novartis and Eli Lilly to identify hidden drug targets. This technical approach leverages protein structure prediction to bypass traditional discovery bottlenecks. It moves AI-designed medicine closer to clinical reality.